BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20683026)

  • 21. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
    Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
    Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
    Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
    Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma.
    Catarino RJ; Breda E; Coelho V; Pinto D; Sousa H; Lopes C; Medeiros R
    Head Neck; 2006 Jul; 28(7):603-8. PubMed ID: 16691558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between cyclin D1 (CCND1) polymorphism and gastric cancer risk in Japanese population.
    Tahara T; Arisawa T; Shibata T; Yamashita H; Hirata I
    Hepatogastroenterology; 2009; 56(93):1232-5. PubMed ID: 19760977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor.
    Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
    BMC Cancer; 2008 Sep; 8():272. PubMed ID: 18822177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study.
    Probst-Hensch NM; Sun CL; Van Den Berg D; Ceschi M; Koh WP; Yu MC
    Carcinogenesis; 2006 Dec; 27(12):2475-82. PubMed ID: 16829689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in taiwan.
    Tsai MH; Tsai CW; Tsou YA; Hua CH; Hsu CF; Bau DT
    Anticancer Res; 2011 Jan; 31(1):227-31. PubMed ID: 21273603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of cyclin D1 G870A polymorphism with susceptibility to gastric cancers in Korean male patients.
    Song JH; Kim CJ; Cho YG; Park YK; Nam SW; Yoo NJ; Lee JY; Park WS
    Neoplasma; 2007; 54(3):235-9. PubMed ID: 17447856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients.
    Hsia TC; Liu CJ; Lin CH; Chang WS; Chu CC; Hang LW; Lee HZ; Lo WC; Bau DT
    Anticancer Res; 2011 Oct; 31(10):3601-5. PubMed ID: 21965784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis.
    Cacina C; Yaylim-Eraltan I; Arikan S; Saglam EK; Zeybek U; Isbir T
    In Vivo; 2010; 24(2):179-83. PubMed ID: 20363991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
    Zhang W; Gordon M; Press OA; Rhodes K; Vallböhmer D; Yang DY; Park D; Fazzone W; Schultheis A; Sherrod AE; Iqbal S; Groshen S; Lenz HJ
    Pharmacogenet Genomics; 2006 Jul; 16(7):475-83. PubMed ID: 16788380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
    Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
    Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
    Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
    Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case-control study of cyclin D1 CCND1 870A-->G polymorphism and bladder cancer.
    Cortessis VK; Siegmund K; Xue S; Ross RK; Yu MC
    Carcinogenesis; 2003 Oct; 24(10):1645-50. PubMed ID: 12896908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.
    Liu B; Zhang Y; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
    Mol Carcinog; 2010 Jan; 49(1):75-84. PubMed ID: 19795398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions.
    Huang M; Spitz MR; Gu J; Lee JJ; Lin J; Lippman SM; Wu X
    Carcinogenesis; 2006 Oct; 27(10):2034-7. PubMed ID: 16638786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population.
    Qiuling S; Yuxin Z; Suhua Z; Cheng X; Shuguang L; Fengsheng H
    Carcinogenesis; 2003 Sep; 24(9):1499-503. PubMed ID: 12807740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in cyclin D1 gene and hepatocellular carcinoma.
    Zhang YJ; Chen SY; Chen CJ; Santella RM
    Mol Carcinog; 2002 Feb; 33(2):125-9. PubMed ID: 11813305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
    Naidu R; Yip CH; Taib NA
    Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.